Use of the current cardiac inotropic agent dobutamine in pediatric surgical clinics
Ismail-Zade, I.A.; Trifonova, N.A.; Stepanenko, S.M.
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 3: 31-34
1994
ISSN/ISBN: 0869-6047 PMID: 7516218 Document Number: 429861
Document emailed within 1 workday
Related Documents
Huss, P.; Miller, J.; Unverferth, D.V.; Leier, C.V. 1981: The new inotropic drug, dobutamine Heart and Lung: the Journal of Critical Care 10(1): 121-126Cleary, J.D. 1988: Two inotropic agents: dopamine and dobutamine Pediatric Nursing 14(5): 414
Sun, B. 1997: Current progress of clinical trials for new drug evaluation in neonatal and pediatric clinics in China Zhongguo Yao Li Xue Bao 18(6): 537-539
Bazin, J.E.; Giannelloni, C.; Dauphin, C.; Curt, I.; Montétagaud, M.; Motreff, P.; Pierre-Justin, E.; Lusson, J.R. 1997: Evaluation of sevoflurane, new anesthetic agent during pediatric cardiac catheterization Archives des Maladies du Coeur et des Vaisseaux 90(5): 657-660
Shabanov, A.N.; Odinets, E.E.; Troshin, V.M. 1971: Current status of prevention of postoperative suppurative and septic complications in surgical clinics (literature review) Khirurgiia 47(1): 137-141
Renard, M.; Jacobs, P.; Melot, C.; Dresse, A.; Bernard, R. 1984: Sulmazole: a new positive inotropic agent Annales de Cardiologie et d'Angeiologie 33(4): 219-222
Kasama, S.; Toyama, T.; Hoshizaki, H.; Oshima, S.; Taniguchi, K.; Iwasaki, T.; Suzuki, T.; Nagai, R. 2000: Prediction of cardiac sympathetic nerve activity and cardiac functional outcome after treatment in patients with dilated cardiomyopathy: examination using dobutamine gated blood pool scintigraphy Journal of Cardiology 36(1): 29-35
Ishihata, A.; Kushida, H.; Endoh, M. 1988: Enantiomers of dobutamine increase the force of contraction via beta adrenoceptors, but antagonize competitively the positive inotropic effect mediated by alpha-1 adrenoceptors in the rabbit ventricular myocardium Journal of Pharmacology and Experimental Therapeutics 246(3): 1080-1087
El Allaf, D.; D'Orio, V.; Cremers, S.; Carlier, J. 1984: Acute clinical benefits of a new inotropic agent AR-L 115 BS after I.v. and oral administration Giornale Italiano di Cardiologia 14(10): 830-834
Kabela, E.; Michaels, D.C.; Felice, E.L. 1979: Effects of a new positive inotropic agent on heart failure of a cardiopulmonary preparation Archivos del Instituto de Cardiologia de Mexico 49(5): 892-907
Han, W.; Qin, Y.; Zhang, Z.; Zhou, S.; Yang, Z. 1994: Inotropic effect of novel domestic cardiotonic agent, vesnarinone--test in vitro Hua Xi Yi Ke da Xue Xue Bao 25(3): 316-320
Kobayashi, M.; Nakamura, H.; Kobayashi, J.; Ohizumi, Y. 1991: Mechanism of inotropic action of xestoquinone, a novel cardiotonic agent isolated from a sea sponge Journal of Pharmacology and Experimental Therapeutics 257(1): 82-89
Beregi, J.P.; Escande, D.; Coudray, N.; Chemla, D.; Mestre, M.; Péry, N.; Lecarpentier, Y. 1994: Positive inotropic and lusitropic effect of RP 62719, a new class IIi antiarrhythmia agent Archives des Maladies du Coeur et des Vaisseaux 87(2): 263-269
Armah, B.I.; Hofferber, E.; Stenzel, W. 1988: Pharmacological properties of the positive inotropic and alpha 1-adrenoceptor blocking agent saterinone Arzneimittel-Forschung 38(9): 1287-1292
Wollschläger, H.; Drexler, H.; Löllgen, H.; Just, H. 1981: The hemodynamic effect of AR-L 115 BS, a new positive-inotropic agent, in patients with left ventricular failure Arzneimittel-Forschung 31(1a): 248-250
Inoue, M.; Hori, M.; Nakajima, S.; Kitakaze, M.; Fukunami, M.; Ishida, Y.; Abe, H. 1984: Effects of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl] -2(1H)-quinolinone (OPC-8212), a new inotropic agent, on cardiotonic activity and coronary hemodynamics Arzneimittel-Forschung 34(3a): 355-359
Shimizu, T.; Osumi, T.; Niimi, K.; Nakagawa, K. 1984: Physico-chemical properties and stabilities of a new positive inotropic agent, 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl] -2(1H)-quinolinone (OPC-8212) Arzneimittel-Forschung 34(3a): 334-341
Klein, G.; Sauer, E.; Bauer, R.; Wirtzfeld, A.; Sebening, H. 1981: The comparison of the effects of AR-L 115 BS and dobutamine in patients with severe cardiac failure Arzneimittel-Forschung 31(1a): 257-259
Sethna, D.H.; Gray, R.J.; Moffitt, E.A.; Bussell, J.A.; Raymond, M.J.; Conklin, C.M.; Matloff, J.M. 1982: Dobutamine and cardiac oxygen balance in patients following myocardial revascularization Anesthesia and Analgesia 61(11): 917-920
Mariotti, E.; Agostini, A.; Angelucci, E.; Cesaroni, P.; Lucarelli, G.; Sgarbi, E. 1993: Cardiac study by dobutamine stress echocardiography in thalassemic patients Bone Marrow Transplantation 12(Suppl 1): 14-15